4.7 Article

MyD88-dependent toll-like receptor signaling is required for murine macrophages response to IS2

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 11, Issue 10, Pages 1578-1583

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2011.05.017

Keywords

beta-glucan; IS2; TLR; MyD88; MAPKs

Funding

  1. Konkuk University

Ask authors/readers for more resources

IS2, a soluble beta-glucan isolated from the cell wall of mutated Saccharomyces cerevisiae (S. cerevisiae) enhances the immune response compared to the wild type (WT) beta-glucan. In the present investigation we report that Toll-like receptor (TLR)/MyD88 signaling pathway was responsible in IS2 beta-glucan-mediated cellular response in RAW264.7 murine macrophages. Data revealed that IS2 beta-glucan significantly up-regulated the TLR2/TLR4 expression. Moreover. TLR2/TLR4 responds to 152 resulting in murine macrophage activation. In addition, the IS2 signal led to cytokine secretions of IL-6 and TNF-alpha. In the case of thioglycolate-elicited peritoneal macrophages from MyD88-deficient mice, the decrease in cytokines was observed. Further the mitogen-activated protein kinases (MAPKs) phosphorylation was evident and degradation of I kappa B-alpha was increased after stimulation with IS2 beta-glucan. Further examination with MyD88-deficient mice revealed that the MyD88 pathway might play an important role for IS2 beta-glucan-mediated activation of macrophages. (C) 2011 Published by Elsevier B.V

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

Md Ezazul Haque, Mahbuba Akther, Shofiul Azam, In-Su Kim, Yuxi Lin, Young-Ho Lee, Dong-Kug Choi

Summary: In Parkinson's disease, the aggregated alpha-synuclein in Lewy bodies and mitochondrial dysfunction play crucial roles in neurodegeneration, with interactions between aggregated alpha-synuclein and mitochondria potentially leading to neuronal loss, making it an emerging drug target for Parkinson's disease treatment.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Agronomy

Cordycepin from Medicinal Fungi Cordyceps militaris Mitigates Inflammaging-Associated Testicular Damage via Regulating NF-kappa B/MAPKs Signaling in Naturally Aged Rats

Spandana Rajendra Kopalli, Kyu-Min Cha, Jae Youl Cho, Si-Kwan Kim, Sushruta Koppula

Summary: This study investigated the beneficial effects of cordycepin on aging-associated testicular inflammation and serum biochemical changes in naturally aged rats. The results showed that cordycepin treatment significantly improved the altered biochemical parameters and attenuated the increased expression of inflammatory mediators in aged rats.

MYCOBIOLOGY (2022)

Review Biochemistry & Molecular Biology

Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders

Rengasamy Balakrishnan, Duk-Yeon Cho, In-Su Kim, Sang-Ho Seol, Dong-Kug Choi

Summary: Neurological disorders are an important global health issue, and there is a lack of effective treatment options. Alpha- and beta-asarone, secondary metabolites found in plants, show potential neuroprotective effects. They act through multiple mechanisms, including antioxidant, anti-inflammatory, and antiapoptotic effects, making them a promising therapeutic approach for neurodegenerative diseases.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Piperine and Its Metabolite's Pharmacology in Neurodegenerative and Neurological Diseases

Shofiul Azam, Ju-Young Park, In-Su Kim, Dong-Kug Choi

Summary: Piperine (PIP) has shown potential therapeutic effects in various diseases, including inflammation, cardiac and hepatic diseases, neurodegenerative diseases, and cancer. Although PIP has poor pharmacokinetic properties, its interaction with metabolic enzymes and the Monoamine oxide B (MAO-B) active site make it a xenobiotics bioenhancer and a potential MAO-B inhibitor. Advancements in pharmaceutical technology have improved PIP's limitations. However, the structure activity relationship (SAR) study suggests that some of PIP's metabolites may be toxic or have pharmacological potential.

BIOMEDICINES (2022)

Article Biochemistry & Molecular Biology

Apigenin Isolated from Carduus crispus Protects against H2O2-Induced Oxidative Damage and Spermatogenic Expression Changes in GC-2spd Sperm Cells

Spandana Rajendra Kopalli, Sung-Kwang Yoo, Bokyung Kim, Si-Kwan Kim, Sushruta Koppula

Summary: This study demonstrated that apigenin isolated from Carduus crispus can protect the testes from oxidative damage. Apigenin can inhibit H2O2-induced cellular damage and increase ROS levels, and it can also restore the expression levels of antioxidants and spermatogenesis-associated molecules.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Dioscin-Mediated Autophagy Alleviates MPP+-Induced Neuronal Degeneration: An In Vitro Parkinson's Disease Model

Shofiul Azam, Md. Ezazul Haque, Duk-Yeon Cho, Joon-Soo Kim, Md. Jakaria, In-Su Kim, Dong-Kug Choi

Summary: Dioscin treatment can protect neuronal cells by inducing autophagy and suppressing the mitochondrial apoptosis pathway, reducing apoptosis and autophagic flux impairment caused by MPP+.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

Group I mGluRs in Therapy and Diagnosis of Parkinson's Disease: Focus on mGluR5 Subtype

Shofiul Azam, Md. Jakaria, JoonSoo Kim, Jaeyong Ahn, In-Su Kim, Dong-Kug Choi

Summary: Metabotropic glutamate receptors (mGluRs), especially mGluR5, play important roles in neurodegenerative diseases and neuropsychiatric disorders. Recent research suggests that mGluR5 radioligands could be used to assess disease progression and track drug properties.

BIOMEDICINES (2022)

Review Biochemistry & Molecular Biology

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis

Spandana Rajendra Kopalli, Venkata Prakash Annamneedi, Sushruta Koppula

Summary: Atopic dermatitis (AD) is a chronic inflammatory skin disease caused by dysregulation of cytokines and other immune mediators. The JAK/STAT pathway plays a crucial role in AD pathogenesis, and its dysregulation can lead to inflammation and pruritus. SOCS proteins negatively regulate the immune-related inflammatory responses mediated by the JAK/STAT pathway. Natural product-derived biomolecules targeting JAK/STAT/SOCS signaling have shown potential in treating AD and other inflammatory disorders.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Dioscorea nipponica Makino Rhizome Extract and Its Active Compound Dioscin Protect against Neuroinflammation and Scopolamine-Induced Memory Deficits

Shofiul Azam, Yon-Suk Kim, Md Jakaria, Ye-Ji Yu, Jae-Yong Ahn, In-Su Kim, Dong-Kug Choi

Summary: The study shows that Dioscorea nipponica Makino ethanol extract and its active compound dioscin can protect against neurotoxicity by inhibiting NF-kappa B phosphorylation and upregulating neurotrophic factor BDNF expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Physical

Polyphenols Coordinated with Cu (II) in an Aqueous System Build Ion-Channel Coatings on Hair Surfaces

Lei Jin, Daemyoung Yun, Wei Zhang, Jinsung Lee, Hongchul Shin, Donghyuk Kim, Tae-Bong Kang, Hyung-Sik Won, Hohyoun Jang, Whangi Kim

Summary: Recently, there has been a renewed interest in hair dyeing due to developments in cosmetics. However, concerns over hair damage during the dyeing process have increased hesitation. This study focuses on developing hair dyes with minimal side effects by using natural-extract polyphenols, pyrogallol, and gallic acid coordinated by CuCl2. These polyphenols form an ion-channel coating on the hair surface, protecting it from damage. The results show successful hair dyeing using the polyphenol-based dye reagent, with increased hair thickness and varying tensile strength.

MATERIALS (2023)

Article Infectious Diseases

10-mer and 9-mer WALK Peptides with Both Antibacterial and Anti-Inflammatory Activities

Su-Jin Kim, Tae-Bong Kang, Dong-Hyuk Kim, Minho Keum, Sung-Hee Lee, Ji-Hun Kim, Sang-Hyuck Lee, Jihoon Kim, Hyuk-Jung Kweon, Jae-Won Park, Beom-Jun Kim, Hyung-Sik Won

Summary: Natural antimicrobial peptides (AMPs) have potential as therapeutic agents for infectious inflammation. Two peptides, WALK244.04 and WALK243.04, showed promising antibacterial and anti-inflammatory activities.

ANTIBIOTICS-BASEL (2022)

Article Biochemistry & Molecular Biology

Cornus officinalis Seed Extract Inhibits AIM2-Inflammasome Activation and Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation

Se-Bin Lee, Ju-Hui Kang, Eun-Jung Sim, Ye-Rin Jung, Jeong-Hyeon Kim, Prima F. Hillman, Sang-Jip Nam, Tae-Bong Kang

Summary: This study investigated the inhibitory activity of ethanolic extracts from Cornus officinalis seeds on AIM2 inflammasome activation. The results showed that the extract could inhibit the release of IL-1 beta induced by dsDNA and alleviate psoriasis-like symptoms in a mouse model.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation

Ju-Hui Kang, Se-Bin Lee, Jiu Seok, Dong-Hyuk Kim, Gaeun Ma, Jooho Park, Ae Jin Jeong, Sang-Kyu Ye, Tae-Bong Kang

Summary: In this study, a chemical compound called ODZ10117 (ODZ) was found to have anti-inflammatory effects targeting the NLRP3 inflammasome. ODZ inhibited inflammasome activation by disrupting the NLRP3-NEK7 interaction required for its formation. Furthermore, ODZ administration reduced IL-1β release and mortality in mice with sepsis, suggesting its potential as a treatment for NLRP3 inflammasome-associated immune disorders and cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy

So-Hyeon Park, Jun-Hyuck Lee, Seong-Bin Yang, Dong-Nyeong Lee, Tae-Bong Kang, Jooho Park

Summary: A novel peptide and drug conjugate (PDC) called RR-BA was developed using a cathepsin-B-specific peptide (RR) and bile acid (BA), which could self-assemble in an aqueous solution to form stable nanoparticles. The nano-sized RR-BA conjugate exhibited significant inhibitory effects on cathepsin B and showed anticancer effects against mouse colorectal cancer cells (CT26). In vivo experiments in CT26 tumor-bearing mice also confirmed its therapeutic effect and low toxicity. Therefore, the RR-BA conjugate holds promise as an effective anticancer drug candidate for targeting cathepsin B in cancer therapy.

PHARMACEUTICS (2023)

Review Chemistry, Medicinal

Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy

Monu Kumar Kashyap, Shubhada V. Mangrulkar, Sapana Kushwaha, Akash Ved, Mayur B. Kale, Nitu L. Wankhede, Brijesh G. Taksande, Aman B. Upaganlawar, Milind J. Umekar, Sushruta Koppula, Spandana Rajendra Kopalli

Summary: Cardiotoxicity is a well-known adverse effect of cancer-related therapy, and it significantly affects patient outcomes and quality of life. The use of antineoplastic drugs to treat colorectal cancers (CRCs) can result in cardiac complications. The mechanisms underlying cardiotoxicity associated with CRC treatment are complex and involve the modulation of various signaling pathways, ultimately damaging cardiac tissue. Therefore, the identification and management of cardiotoxicity associated with CRC drug therapy have become increasingly important.

PHARMACEUTICALS (2023)

Article Immunology

IFITM3 overexpression reverses insufficient healing benefits of small extracellular vesicles from high-fat-diet BMSCs in sepsis via the HMGB1 pathway

Jun Cui, Cheng Chen, Xiao Zhou, Wenju Shan, Yuhong Jian, Panpan Li, Yang Sun, Wei Yi

Summary: Bone marrow mesenchymal stem cells (BMSCs) are a promising therapy for sepsis, but metabolic syndromes threaten their effectiveness. This study investigated the potential of small extracellular vesicles from high-fat diet BMSCs in sepsis-induced liver-heart axis injury.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

MMP-9 inhibition alleviates postoperative cognitive dysfunction by improving glymphatic function via regulating AQP4 polarity

Binbin Zhu, Angyang Cao, Chunqu Chen, Weijian Zhou, Wenjun Luo, Yu Gui, Qinwen Wang, Zhipeng Xu, Jianhua Wang

Summary: GM6001 alleviates postoperative cognitive deficits and neuroinflammation, preserves blood-brain barrier integrity, and rescues aquaporin-4 mislocalization. MMP-9 inhibition plays a dual role in cognitive protection through direct anti-neuroinflammatory effects and regulation of aquaporin-4 membrane distribution.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

S1PR2 inhibition mitigates cognitive deficit in diabetic mice by modulating microglial activation via Akt-p53-TIGAR pathway

Anika Sood, Valencia Fernandes, Kumari Preeti, Shruti Rajan, Dharmendra Kumar Khatri, Shashi Bala Singh

Summary: S1PR2 inhibitor improves cognitive function and skews microglia toward anti-inflammatory phenotype in type 2 diabetic mice, promising to be a potential therapy for neuroinflammation.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Cytokine, chemokine alterations and immune cell infiltration in Radiation-induced lung injury: Implications for prevention and management

Haochun Guo, Ran Yu, Haijun Zhang, Wanpeng Wang

Summary: Radiation therapy is an effective treatment for thoracic malignancies, but it can cause radiation-induced lung injury (RILI), including radiation pneumonitis (RP) and radiation pulmonary fibrosis (RPF). The damage to normal lung cells during radiation treatment leads to a pulmonary inflammatory response, resulting in RP and RPF.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers

Guanghui Wang, Haotian Zheng, Yunzhi Xiang, Yadong Wang, Kai Wang, Xiaoyang Ren, Jiajun Du

Summary: This study identified a T-cell synthetic driver-associated prognostic model that accurately predicted prognosis and effectiveness of immunotherapy in LUAD patients. It also highlighted the role of LDHA in promoting tumor cell proliferation, invasion, and resistance to treatment, as well as its involvement in immune escape within the tumor microenvironment. These findings provide a promising new therapeutic strategy for LUAD.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Identification of immunological characteristics and cuproptosis-related molecular clusters in primary Sjogren's syndrome

Bowen Wei, Aihua Wang, Wei Liu, Qingyun Yue, Yihua Fan, Bin Xue, Siwei Wang

Summary: This study systematically analyzed the association between pSS and cuproptosis, established a predictive model based on 5 genes, explored the pathogenic mechanisms and novel therapeutic strategies for pSS, and identified EED, CBL, and NFU1 as potential targets for treatment.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Site-selective synthesis and pharmacological elucidation of novel semi-synthetic analogues of koenimbine as a potential anti-inflammatory agent

Nusrit Iqbal Andrabi, Aminur R. Sarkar, Syed Assim Haq, Diljeet Kumar, Dilpreet Kour, Diksha Saroch, Sanket Kumar Shukla, Ajay Kumar, Asha Bhagat, Asif Ali, Gurleen Kour, Zabeer Ahmed

Summary: Koenimbine and its novel semi-synthetic derivative 1G demonstrate significant anti-inflammatory effects by downregulating the nuclear factor kappa-B (NF-kappa B) signaling pathway.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Protective effect of arctiin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor

Jing-Mei Lu, Xiang Xu, Fumie Aosai, Ming-Yue Zhang, Lian-Xun Piao

Summary: This study found that arctiin can improve allergic acute liver injury caused by T.g.HSP70 by inhibiting TLR4 signaling and reducing the production of inflammatory mediators.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Arabinose confers protection against intestinal injury by improving integrity of intestinal mucosal barrier

Minxuan Xu, Fang Shi, Yongshen Gao, Shumei Han, Chensuo Huang, Qinsheng Hou, Xiaoweng Wen, Bengshi Wang, Zhenyu Zhu, Lei Zou, Mingxin Xiong, Wei Dong, Jun Tan

Summary: There is a growing body of research highlighting the involvement of metabolic imbalance and the inflammatory response in the advancement of colitis. This study recognizes arabinose as a significant protector of the intestinal mucosal barrier, reducing damage to the intestines. In addition, lower levels of arabinose in the bloodstream are associated with a higher severity of inflammatory bowel disease and colorectal cancer.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2

Yueqing Han, Haoxin Song, Yanshan Li, Rongxin Li, Ling Chen, Bo Gao, Yijun Chen, Shuzhen Wang

Summary: The combination of tetracycline antibiotics, demeclocycline (D), chlortetracycline (C), and minocycline (M), showed therapeutic potential against liver fibrosis by inhibiting the activation of hepatic stellate cells and the MAPK signaling. This study suggests that tetracyclines may be repurposed for the treatment of liver fibrosis.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Spleen contributes to chronic restraint stress-induced lung injury through splenic CD11b+cells

Yu Li, Hailing Liu, Danwen Zhao, Danjie Zhang

Summary: Chronic stress can lead to lung injury, with the spleen playing a crucial role. This study found that the spleen contributes to chronic restraint stress-induced lung injury, and splenic CD11b+ cells may be an important factor in this process.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

NMAAP1 regulated macrophage polarizion into M1 type through glycolysis stimulated with BCG

Yingqian Mi, Mengyan Tang, Qiong Wu, Yinan Wang, Qihui Liu, Pei Zhu, Xiaoyang Xue, Yuntong Liu, Xinyu Chai, Yuyang Hou, Dongmei Yan

Summary: BCG therapy can induce macrophage polarization to the M1 type, and NMAAP1 plays a crucial role in this process by regulating glycolysis and HIF-1α expression. This promotes the antitumor effect of macrophages.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques

Xiaosheng Liu, Tingxia Lv, Xiuxia Li, Jing Xue, Ling Lin, Lianfeng Lu, Xiaodi Li, Yang Yang, Yuanni Wu, Qiang Wei, Wei Cao, Taisheng Li

Summary: LLDT-8 exhibits notable efficacy in alleviating immune activation in both an in vivo animal model and in vitro human cell experiments, suggesting its potential as a drug for managing systemic immune activation associated with SIV/HIV infection.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Mesenchymal stem cells attenuate systemic lupus erythematosus by inhibiting NLRP3 inflammasome activation through Pim-1 kinase

Honghong Yu, Qi Li, Huimin Zhu, Chang Liu, Weiwei Chen, Lingyun Sun

Summary: The activation of the inflammasome plays a critical role in the pathogenesis of systemic lupus erythematosus (SLE), and mesenchymal stem cells (MSC) have been shown to alleviate SLE by suppressing inflammasome activation. This study found that the NLRP3 inflammasome was activated in macrophages from SLE patients and mice, and its activation correlated with disease activity. After MSC transplantation, the severity of SLE was reduced, and NLRP3 inflammasome activation was inhibited. These findings suggest that MSC suppress inflammasome activation and provide a potential therapeutic target for SLE.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

Article Immunology

Histone deacetylase 3 inhibition alleviates 2,4-dinitrochlorobenzene-in-duced atopic dermatitis via epigenetically upregulating Nrf2/HO-1 signaling pathway

Wei Zhou, Dan Zeng, Shunan Liu, Yunxia Huang, Fenglin Lv, Weikang Zhou

Summary: This study found that inhibiting HDAC3 can protect the skin from atopic dermatitis by activating the Nrf2 transcription to upregulate Nrf2/HO-1 signaling pathway activity.

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)